<!DOCTYPE html>

<!--[if lt IE 7]> <html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en"> <![endif]-->
<!--[if IE 7]>    <html class="no-js lt-ie9 lt-ie8" lang="en"> <![endif]-->
<!--[if IE 8]>    <html class="no-js lt-ie9" lang="en"> <![endif]-->
<!--[if gt IE 8]><!--> <html class="no-js" lang="en"> <!--<![endif]-->
<head><meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width,initial-scale=1" name="viewport"/>
<link href="/xmlui/themes/Mirage2/images/favicon.ico" rel="shortcut icon"/>
<link href="/xmlui/themes/Mirage2/images/apple-touch-icon.png" rel="apple-touch-icon"/>
<meta content="DSpace 5.8" name="Generator"/>
<link href="https://fonts.googleapis.com/css?family=PT+Sans:400,700|Ubuntu:400,500,700italic|Droid+Sans:400,700" rel="stylesheet" type="text/css"/>
<link href="/xmlui/themes/Mirage2/styles/main.css" rel="stylesheet"/>
<link href="https://papyrus.bib.umontreal.ca:443/xmlui/description.xml" rel="search" title="DSpace" type="application/opensearchdescription+xml"/>
<script>
                //Clear default text of emty text areas on focus
                function tFocus(element)
                {
                if (element.value == ''){element.value='';}
                }
                //Clear default text of emty text areas on submit
                function tSubmit(form)
                {
                var defaultedElements = document.getElementsByTagName("textarea");
                for (var i=0; i != defaultedElements.length; i++){
                if (defaultedElements[i].value == ''){
                defaultedElements[i].value='';}}
                }
                //Disable pressing 'enter' key to submit a form (otherwise pressing 'enter' causes a submission to start over)
                function disableEnterKey(e)
                {
                var key;

                if(window.event)
                key = window.event.keyCode;     //Internet Explorer
                else
                key = e.which;     //Firefox and Netscape

                if(key == 13)  //if "Enter" pressed, then disable!
                return false;
                else
                return true;
                }
            </script><!--[if lt IE 9]>
                <script src="/xmlui/themes/Mirage2/vendor/html5shiv/dist/html5shiv.js"> </script>
                <script src="/xmlui/themes/Mirage2/vendor/respond/respond.min.js"> </script>
                <![endif]--><script src="/xmlui/themes/Mirage2/vendor/modernizr/modernizr.js"> </script><script src="https://www.bib.umontreal.ca/modele/urgence-udem/1.0.0/urgence-udem.js"></script>
<title>Étude de l'endocytose du récepteur PD-1 dans les lymphocytes T humains</title>
<meta content="Dr8axyf94eWBJ8HQjNW4eKxTumAAPsNbvRwpJYMbgGs" name="google-site-verification"/>
<link href="http://purl.org/dc/terms/" rel="schema.DCTERMS">
<link href="http://purl.org/dc/elements/1.1/" rel="schema.DC">
<meta content="Rudd, Christopher E." name="DC.contributor">
<meta content="Ben Saad, Elham" name="DC.creator">
<meta content="2020-09-24T19:51:22Z" name="DCTERMS.dateAccepted" scheme="DCTERMS.W3CDTF">
<meta content="NO_RESTRICTION" name="DCTERMS.available" scheme="DCTERMS.W3CDTF" xml:lang="fr">
<meta content="2020-09-24T19:51:22Z" name="DCTERMS.available" scheme="DCTERMS.W3CDTF">
<meta content="2020-06-04" name="DCTERMS.issued" scheme="DCTERMS.W3CDTF">
<meta content="2019-08" name="DC.date" scheme="DCTERMS.W3CDTF"/>
<meta content="http://hdl.handle.net/1866/23924" name="DC.identifier" scheme="DCTERMS.URI"/>
<meta content="Récepteur PD-1" name="DC.subject" xml:lang="fr"/>
<meta content="Lymphocytes T" name="DC.subject" xml:lang="fr"/>
<meta content="Endocytose" name="DC.subject" xml:lang="fr"/>
<meta content="Inhibiteurs de points de contrôle immunitaires" name="DC.subject" xml:lang="fr"/>
<meta content="Nivolumab" name="DC.subject" xml:lang="fr"/>
<meta content="Pembrolizumab" name="DC.subject" xml:lang="fr"/>
<meta content="Anticorps anti-PD-1" name="DC.subject" xml:lang="fr"/>
<meta content="PD-1 receptor" name="DC.subject" xml:lang="fr"/>
<meta content="T lymphocyte" name="DC.subject" xml:lang="fr"/>
<meta content="Immune checkpoint blockade" name="DC.subject" xml:lang="fr"/>
<meta content="Anti-PD-1 antibodies" name="DC.subject" xml:lang="fr"/>
<meta content="Biology - Molecular / Biologie - Biologie moléculaire (UMI : 0307)" name="DC.subject" xml:lang="fr"/>
<meta content="Étude de l'endocytose du récepteur PD-1 dans les lymphocytes T humains" name="DC.title" xml:lang="fr"/>
<meta content="Thèse ou mémoire / Thesis or Dissertation" name="DC.type"/>
<meta content="PD-1 (Programmed Cell death protein -1) est un récepteur co-inhibiteur exprimé à la surface de  lymphocytes T (LT) activés. Ce récepteur joue un rôle important dans le maintien de la tolérance périphérique tout en protégeant contre les maladies auto-immunes et inflammatoires. Cependant, une expression élevée et permanente de PD-1 et ses ligands PD-L1 et PD-L2 (PD-Ls) perturbe la réponse immunitaire contre les pathogènes et les cellules tumorales.
     Les inhibiteurs de points de contrôle immunitaires (ICI) ciblant l'axe PD-1/PD-Ls représentent aujourd’hui une avancé majeure dans le traitement de différents types de cancer, tant sur le plan de l’efficacité que de la tolérance. Le nivolumab (nivo) et le pembrolizumab (pembro) sont deux anticorps monoclonaux (AcM) anti-PD-1 qui bloquent l’interaction de PD-1 avec ses ligands. Ces AcM ont montré des résultats prometteurs dans le traitement de multiples types de cancers comme le mélanome, le cancer bronchique non à petites cellules, le carcinome à cellules rénales, etc. 
     Malgré l’importance thérapeutique de nivo et de pembro dans le cancer, aucune étude n’a défini le devenir de PD-1 après la liaison à ces deux AcM. 
     L’objectif de cette étude a été donc d’évaluer l’endocytose de PD-1 suite au liaison à des AcM anti-PD-1 (clone J110, nivo, pembro) et de déterminer s’il y a différence entre nivo et pembro vis à vis leur capacités à induire l'internalisation de  PD-1.
      L’étude de l’endocytose de PD-1 a été réalisé sur des LT humains obtenus à partir du sang périphérique de donneurs sains et activés avec des Ac anti-CD3/anti-CD28 ou concanavaline A afin d’exprimer le récepteur PD-1. L’analyse des données par cytométrie en flux a montré que l’engagement de PD-1 avec l’Ac anti-PD-1 (clone J110) induit son endocytose dans les LT humains et que 50% de la totalité de PD-1 de surface est internalisé dans les premiers 30 minutes  suivant l’incubation de cellules à 37°C, suivi d’un taux d’endocytose plus lent (56% en 60min).
     Notre étude a montré également que la liaison de nivo et de pembro au PD-1 induit  son endocytose et que la plupart de récepteur est internalisée dans les 30 min suivant l’incubation de cellules à 37°C. Toutefois, 32 à 50% des récepteurs sont résistants à l’endocytose. 
      L’analyse comparative de nivo et de pembro a révélé une différence statistiquement significative (p=0.03) entre le taux d’internalisation du complexe PD-1/nivo et celui du PD-1/pembro (46% versus 25% en 30min, respectivement). Même à des concentrations élevées de pembro, la liaison de nivo induit une meilleure internalisation de PD-1, ce qui suggère que nivo pourrait être plus efficace.
      Bien que les ICI comme nivo et pembro sont connus de bloquer l’interaction de PD-1 avec ses ligands, PD-L1 et PD-L2, notre étude a montré pour la première fois que ce deux AcM induisent aussi l’endocytose du récepteur PD-1 dans les LT humains avec des taux différents, et que 32% à 50% de récepteurs PD-1 sont résistants à l’endocytose. Ces résultats pourraient être exploités pour améliorer l’internalisation de PD-1 dans les LT humains et par la suite augmenter les potentiels thérapeutiques de nivolumab et de pembrolizumab dans le traitement du cancer.

Mots clés : Récepteur PD-1, Ligands de PD-1, Lymphocytes T, Inhibiteurs de point de contrôle immunitaires, Anticorps anti-PD-1, Nivolumab, Pembrolizumab,  Endocytose, Cancer" name="DCTERMS.abstract" xml:lang="fr"/>
<meta content="PD-1 (Programmed Cell death protein -1) is a co-inhibitory receptor expressed on the surface of activated T cells. It plays an important role in maintaining peripheral tolerance and protecting against autoimmune and inflammatory diseases. However, permanent expression of PD-1 and its ligands PD-L1/ PD-L2 (PD-Ls) disrupts the immune response against pathogens and tumor cells.
      Immune checkpoint blockade (ICB) targeting the PD-1/PD-Ls axis has revolutionized the treatment of many cancers. Nivolumab (nivo) and pembrolizumab (pembro) are two anti-PD-1 monoclonal antibodies (mAb) that block the interaction between PD-1 and its ligands. They have shown promising results in the treatment of multiple types of cancers such as melanoma, non-small cell lung cancer, renal cell carcinoma, etc. 
     Surprisingly, despite the success of anti-PD-1 in cancer immunotherapy, no-one has defined the destiny of surface PD-1 following antibody binding. Therefore, the objective of my master thesis was to define the fate of surface PD-1 following antibody binding and whether different anti-PD-1 Abs in the clinic differ in their ability to induce PD-1 endocytosis.
       The study of PD-1 endocytosis was performed on human T lymphocytes obtained from peripheral blood of healthy donors and activated with anti-CD3/anti-CD28 Ab or concanavalin A to express PD-1 receptor. Data analysis by flow cytometry showed that following anti-PD-1 Ab binding, 50% of PD-1 becomes endocytosed by 30min.
      In addition, we found that the PD-1 receptor is internalised upon its engagement with nivo and pembro and that most of the receptor is endocytosed within 30 min. However, 32 to 50% of the receptors are resistant to endocytosis.
      The comparative analysis of nivo and pembro has revealed a statistically significant difference (p=0.03) between the internalisation rate of the PD-1/nivo complex versus PD-1/pembro (46% versus 25% by 30min, respectively). Even at high concentrations of pembro, nivo induces better internalization of PD-1, suggesting that nivo could be more effective than pembro.
   Our study showed for the first time that ICB involves not only in the blockade of PD-1/PD-Ls interaction, but also in the endocytosis of PD-1 receptors from the surface of human T-cells, which differs between nivolumab and pembrolizumab. These results could be exploited to increase the therapeutic potential of nivolumab and pembrolizumab in cancer treatment.

Keywords: PD-1 receptor, PD-1 ligands, T lymphocytes, Immune checkpoint blockade, Anti-PD1 antibodies, Nivolumab, Pembrolizumab, Endocytosis, Cancer" name="DCTERMS.abstract" xml:lang="fr"/>
<meta content="fra" name="DCTERMS.language" xml:lang="fr"/>
<meta content="Récepteur PD-1; Lymphocytes T; Endocytose; Inhibiteurs de points de contrôle immunitaires; Nivolumab; Pembrolizumab; Anticorps anti-PD-1; PD-1 receptor; T lymphocyte; Immune checkpoint blockade; Anti-PD-1 antibodies; Biology - Molecular / Biologie - Biologie moléculaire (UMI : 0307); Thèse ou mémoire / Thesis or Dissertation; Biologie moléculaire" name="citation_keywords"/>
<meta content="Étude de l'endocytose du récepteur PD-1 dans les lymphocytes T humains" name="citation_title"/>
<meta content="fra" name="citation_language"/>
<meta content="Ben Saad, Elham" name="citation_author"/>
<meta content="https://papyrus.bib.umontreal.ca/xmlui/bitstream/1866/23924/4/Ben_Saad_Elham_2019_memoire.pdf" name="citation_pdf_url"/>
<meta content="2020-06-04" name="citation_date"/>
<meta content="https://papyrus.bib.umontreal.ca/xmlui/handle/1866/23924" name="citation_abstract_html_url"/>
<script type="text/x-mathjax-config">
                    MathJax.Hub.Config({
                      tex2jax: {
                        inlineMath: [['\\(','\\)']],
                        ignoreClass: "detail-field-data|detailtable|exception"
                      },
                      TeX: {
                        Macros: {
                          AA: '{\\mathring A}'
                        }
                      }
                    });
                </script><script src="//cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML" type="text/javascript"> </script>
</meta></meta></meta></meta></meta></meta></link></link></head><body>
<header>
<div class="navbar navbar-default navbar-static-top" role="navigation">
<div class="container">
<div class="hidden-xs hidden-sm hidden-md" id="um-bandeau" role="banner">
<nav class="um-nav um-nav-hidden" role="navigation">
<span class="hidden">Liens externes</span>
<ul>
<li>
<a href="https://www.umontreal.ca/#udemwww-search-personne">Directories</a>
</li>
<li>
<a href="http://www.umontreal.ca/repertoires/facultes.html">Faculties</a>
</li>
<li>
<a href="http://www.bib.umontreal.ca/">Libraries</a>
</li>
<li>
<a href="http://plancampus.umontreal.ca/">Campus maps</a>
</li>
<li>
<a href="http://www.umontreal.ca/index/az.html">Sites A to Z</a>
</li>
<li>
<a>My UdeM</a>
<ul>
<li>
<a href="https://monudem.umontreal.ca/">My UdeM Portal</a>
</li>
<li>
<a href="https://outlook.umontreal.ca">My email</a>
</li>
<li>
<a href="https://studium.umontreal.ca/">StudiUM</a>
</li>
</ul>
</li>
</ul>
</nav>
<form action="https://google.com/cse" class="um-recherche" id="um-recherche" role="search">
<input name="cx" type="hidden" value="011926736769028447783:qlpu3so2kqq"/><input name="ie" type="hidden" value="ISO-8859-1"/><label class="hidden" for="um-boite-recherche">Search in : </label><span class="um-boite-bouton"><input class="um-boite" id="um-boite-recherche" maxlength="255" name="q" placeholder="UdeM" title="Type your search text" type="text" value=""/><input alt="Search in : " class="um-bouton" src="/xmlui/themes/Mirage2/images/bib-umontreal/loupe.gif" type="image"/></span>
</form>
</div>
<div class="hidden-xs hidden-sm visible-md visible-lg" id="papyrus-deco">
<img alt="Dessin du pavillon Roger Gaudry/Sketch of Roger Gaudry Building" border="0" height="89px" src="/xmlui/themes/Mirage2/images/UdeM.gif" title="Dessin du pavillon Roger Gaudry/Sketch of Roger Gaudry Building" width="193px"/></div>
<div class="navbar-header">
<button class="navbar-toggle" data-toggle="offcanvas" type="button"><span class="sr-only">Toggle navigation</span><span class="icon-bar"></span><span class="icon-bar"></span><span class="icon-bar"></span></button><a class="navbar-brand hidden-xs hidden-sm visible-md visible-lg um-logo-md-lg" href="http://www.umontreal.ca/english/index.html"><img alt="University Home page" src="/xmlui/themes/Mirage2/images/logo-UdeM.svg" title="Back to University Home page"/></a><a class="navbar-brand hidden-xs visible-sm hidden-md hidden-lg um-logo-sm" href="http://www.umontreal.ca/english/index.html"><img alt="University Home page" src="/xmlui/themes/Mirage2/images/logo-UdeM.svg" title="Back to University Home page"/></a><a class="navbar-brand visible-xs hidden-sm hidden-md hidden-lg um-logo-xs" href="http://www.umontreal.ca/english/index.html"><img alt="University Home page" src="/xmlui/themes/Mirage2/images/logo-UdeM.svg" title="Back to University Home page"/></a>
<div class="navbar-brand separateur visible-xs hidden-sm hidden-md hidden-lg um-sep-site-xs"></div>
<div class="navbar-brand separateur hidden-xs visible-sm hidden-md hidden-lg um-sep-site-sm"></div>
<div class="navbar-brand separateur visible-md visible-lg hidden-xs hidden-sm um-sep-site-md-lg"></div>
<div class="navbar-brand visible-md visible-lg hidden-xs hidden-sm um-titre-site-md-lg">
<span class="papyrus-signature">Papyrus</span> :
                                Institutional Repository</div>
<div class="navbar-brand hidden-xs visible-sm hidden-md hidden-lg um-titre-site-sm">
<span class="papyrus-signature">Papyrus</span>
<br/>Institutional Repository</div>
<div class="navbar-brand visible-xs hidden-sm hidden-md hidden-lg um-titre-site-xs">
<span class="papyrus-signature">Papyrus</span>
</div>
<div class="navbar-header pull-right visible-xs hidden-sm hidden-md hidden-lg">
<ul class="nav nav-pills pull-left">
<li class="dropdown" id="ds-language-selection-xs">
<button class="dropdown-toggle navbar-toggle navbar-link" data-toggle="dropdown" href="#" id="language-dropdown-toggle-xs" role="button"><b aria-hidden="true" class="visible-xs glyphicon glyphicon-globe"></b></button>
<ul aria-labelledby="language-dropdown-toggle-xs" class="dropdown-menu pull-right" data-no-collapse="true" role="menu">
<li role="presentation">
<a href="https://papyrus.bib.umontreal.ca:443/xmlui/handle/1866/23924?locale-attribute=fr&amp;show=full">français</a>
</li>
<li class="disabled" role="presentation">
<a href="https://papyrus.bib.umontreal.ca:443/xmlui/handle/1866/23924?locale-attribute=en&amp;show=full">English</a>
</li>
</ul>
</li>
<li>
<form action="/xmlui/login" method="get" style="display: inline">
<button class="navbar-toggle navbar-link"><b aria-hidden="true" class="visible-xs glyphicon glyphicon-user"></b></button>
</form>
</li>
</ul>
</div>
</div>
<div class="navbar-header pull-right hidden-xs">
<div class="nav-language-and-login-lg hidden-xs hidden-sm hidden-md">
<ul class="nav navbar-nav pull-right">
<li class="dropdown" id="ds-language-selection">
<a class="dropdown-toggle" data-toggle="dropdown" href="#" id="language-dropdown-toggle" role="button"><span class="hidden-xs">English <b class="caret"></b></span></a>
<ul aria-labelledby="language-dropdown-toggle" class="dropdown-menu pull-right" data-no-collapse="true" role="menu">
<li role="presentation">
<a href="https://papyrus.bib.umontreal.ca:443/xmlui/handle/1866/23924?locale-attribute=fr&amp;show=full">français</a>
</li>
<li class="disabled" role="presentation">
<a href="https://papyrus.bib.umontreal.ca:443/xmlui/handle/1866/23924?locale-attribute=en&amp;show=full">English</a>
</li>
</ul>
</li>
</ul>
<ul class="nav navbar-nav pull-right">
<li>
<a href="/xmlui/login"><span class="hidden-xs">Login</span></a>
</li>
</ul>
</div>
<div class="hidden-lg">
<ul class="nav navbar-nav pull-right">
<li class="dropdown" id="ds-language-selection">
<a class="dropdown-toggle" data-toggle="dropdown" href="#" id="language-dropdown-toggle" role="button"><span class="hidden-xs">English <b class="caret"></b></span></a>
<ul aria-labelledby="language-dropdown-toggle" class="dropdown-menu pull-right" data-no-collapse="true" role="menu">
<li role="presentation">
<a href="https://papyrus.bib.umontreal.ca:443/xmlui/handle/1866/23924?locale-attribute=fr&amp;show=full">français</a>
</li>
<li class="disabled" role="presentation">
<a href="https://papyrus.bib.umontreal.ca:443/xmlui/handle/1866/23924?locale-attribute=en&amp;show=full">English</a>
</li>
</ul>
</li>
</ul>
<ul class="nav navbar-nav pull-right">
<li>
<a href="/xmlui/login"><span class="hidden-xs">Login</span></a>
</li>
</ul>
</div>
<button class="navbar-toggle visible-sm" data-toggle="offcanvas" type="button"><span class="sr-only">Toggle navigation</span><span class="icon-bar"></span><span class="icon-bar"></span><span class="icon-bar"></span></button>
</div>
</div>
</div>
</header>
<div class="trail-wrapper hidden-print">
<div class="container">
<div class="row">
<div class="col-xs-12">
<div class="breadcrumb dropdown visible-xs">
<a class="dropdown-toggle" data-toggle="dropdown" href="#" id="trail-dropdown-toggle" role="button">View Item <b class="caret"></b></a>
<ul aria-labelledby="trail-dropdown-toggle" class="dropdown-menu" role="menu">
<li role="presentation">
<a href="/xmlui/" role="menuitem"><i aria-hidden="true" class="glyphicon glyphicon-home"></i>  Home</a>
</li>
<li role="presentation">
<a href="/xmlui/handle/1866/1349" role="menuitem">Faculté de médecine</a>
</li>
<li role="presentation">
<a href="/xmlui/handle/1866/2591" role="menuitem">Faculté de médecine – Thèses et mémoires</a>
</li>
<li class="disabled" role="presentation">
<a href="#" role="menuitem">View Item</a>
</li>
</ul>
</div>
<ul class="breadcrumb hidden-xs">
<li>
<i aria-hidden="true" class="glyphicon glyphicon-home"></i>  <a href="/xmlui/">Home</a>
</li>
<li>
<a href="/xmlui/handle/1866/1349">Faculté de médecine</a>
</li>
<li>
<a href="/xmlui/handle/1866/2591">Faculté de médecine – Thèses et mémoires</a>
</li>
<li class="active">View Item</li>
</ul>
</div>
</div>
</div>
</div>
<div class="hidden" id="no-js-warning-wrapper">
<div id="no-js-warning">
<div class="notice failure">JavaScript is disabled for your browser. Some features of this site may not work without it.</div>
</div>
</div>
<div class="container" id="main-container">
<div class="row row-offcanvas row-offcanvas-left">
<div class="horizontal-slider clearfix">
<div class="col-xs-6 col-sm-3 sidebar-offcanvas" id="sidebar" role="navigation">
<div class="word-break hidden-print" id="ds-options">
<div class="ds-option-set" id="ds-search-option">
<form action="/xmlui/discover" class="" id="ds-search-form" method="post">
<fieldset>
<div class="input-group">
<input class="ds-text-field form-control" name="query" placeholder="Search" type="text"/><span class="input-group-btn"><button class="ds-button-field btn" title="Go"><span aria-hidden="true" class="glyphicon glyphicon-search"></span></button></span>
</div>
<div class="radio">
<label><input checked="" id="ds-search-form-scope-all" name="scope" type="radio" value=""/>Search Papyrus</label>
</div>
<div class="radio">
<label><input id="ds-search-form-scope-container" name="scope" type="radio" value="1866/2591"/>Search this Collection</label>
</div>
</fieldset>
</form>
</div>
<h2 class="ds-option-set-head h6">My Account</h2>
<div class="list-group" id="aspect_viewArtifacts_Navigation_list_account">
<div class="list-group-item ds-option details_Papyrus" id="aspect_eperson_Navigation_item_details_Papyrus">To submit an item or subscribe to email alerts.</div>
<div class="list-group-item ds-option">
<span class="bold"><a href="/xmlui/login">Login</a></span>
</div>
<a class="list-group-item ds-option" href="/xmlui/register">New user?</a>
</div>
<h2 class="ds-option-set-head h6">Browse</h2>
<div class="list-group" id="aspect_viewArtifacts_Navigation_list_browse">
<a class="list-group-item active"><span class="h5 list-group-item-heading h5">All of Papyrus</span></a><a class="list-group-item ds-option" href="/xmlui/community-list">Communities and Collections</a><a class="list-group-item ds-option" href="/xmlui/browse?type=title">Titles</a><a class="list-group-item ds-option" href="/xmlui/browse?type=dateissued">Issue Dates</a><a class="list-group-item ds-option" href="/xmlui/browse?type=author">Authors</a><a class="list-group-item ds-option" href="/xmlui/browse?type=advisor">Advisors</a><a class="list-group-item ds-option" href="/xmlui/browse?type=subject">Subjects</a><a class="list-group-item ds-option" href="/xmlui/browse?type=discipline">Disciplines</a><a class="list-group-item ds-option" href="/xmlui/browse?type=affiliation">Affiliation</a><a class="list-group-item ds-option" href="/xmlui/browse?type=titleindex">Titles index</a><a class="list-group-item active"><span class="h5 list-group-item-heading h5">This Collection</span></a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=title">Titles</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=dateissued">Issue Dates</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=author">Authors</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=advisor">Advisors</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=subject">Subjects</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=discipline">Disciplines</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=affiliation">Affiliation</a><a class="list-group-item ds-option" href="/xmlui/handle/1866/2591/browse?type=titleindex">Titles index</a>
</div>
<div class="list-group" id="aspect_viewArtifacts_Navigation_list_context"></div>
<div class="list-group" id="aspect_viewArtifacts_Navigation_list_administrative"></div>
<div class="list-group" id="aspect_discovery_Navigation_list_discovery"></div>
<h2 class="ds-option-set-head h6">Statistics</h2>
<div class="list-group" id="aspect_statistics_Navigation_list_statistics">
<a class="list-group-item ds-option" href="/xmlui/handle/1866/23924/statistics">View Usage Statistics</a>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-12 col-md-9 main-content">
<div>
<div class="ds-static-div primary" id="aspect_artifactbrowser_ItemViewer_div_item-view">
<p class="ds-paragraph item-view-toggle item-view-toggle-top">
<span class="item-view-toggle"><a href="/xmlui/handle/1866/23924">Show item record</a></span>
</p>
<!-- External Metadata URL: cocoon://metadata/handle/1866/23924/mets.xml-->
<h2 class="page-header first-page-header">Étude de l'endocytose du récepteur PD-1 dans les lymphocytes T humains</h2>
<div class="ds-table-responsive">
<table class="ds-includeSet-table detailtable table table-striped table-hover">
<tr class="ds-table-row odd">
<td class="label-cell">dc.contributor.advisor</td><td class="word-break">Rudd, Christopher E.</td><td></td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.contributor.author</td><td class="word-break">Ben Saad, Elham</td><td></td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.date.accessioned</td><td class="word-break">2020-09-24T19:51:22Z</td><td></td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.date.available</td><td class="word-break">NO_RESTRICTION</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.date.available</td><td class="word-break">2020-09-24T19:51:22Z</td><td></td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.date.issued</td><td class="word-break">2020-06-04</td><td></td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.date.submitted</td><td class="word-break">2019-08</td><td></td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.identifier.uri</td><td class="word-break">http://hdl.handle.net/1866/23924</td><td></td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.subject</td><td class="word-break">Récepteur PD-1</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.subject</td><td class="word-break">Lymphocytes T</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.subject</td><td class="word-break">Endocytose</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.subject</td><td class="word-break">Inhibiteurs de points de contrôle immunitaires</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.subject</td><td class="word-break">Nivolumab</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.subject</td><td class="word-break">Pembrolizumab</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.subject</td><td class="word-break">Anticorps anti-PD-1</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.subject</td><td class="word-break">PD-1 receptor</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.subject</td><td class="word-break">T lymphocyte</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.subject</td><td class="word-break">Immune checkpoint blockade</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.subject</td><td class="word-break">Anti-PD-1 antibodies</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.subject.other</td><td class="word-break">Biology - Molecular / Biologie - Biologie moléculaire (UMI : 0307)</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dc.title</td><td class="word-break">Étude de l'endocytose du récepteur PD-1 dans les lymphocytes T humains</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dc.type</td><td class="word-break">Thèse ou mémoire / Thesis or Dissertation</td><td></td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">etd.degree.discipline</td><td class="word-break">Biologie moléculaire</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">etd.degree.grantor</td><td class="word-break">Université de Montréal</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">etd.degree.level</td><td class="word-break">Maîtrise / Master's</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">etd.degree.name</td><td class="word-break">M. Sc.</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dcterms.abstract</td><td class="word-break">PD-1 (Programmed Cell death protein -1) est un récepteur co-inhibiteur exprimé à la surface de  lymphocytes T (LT) activés. Ce récepteur joue un rôle important dans le maintien de la tolérance périphérique tout en protégeant contre les maladies auto-immunes et inflammatoires. Cependant, une expression élevée et permanente de PD-1 et ses ligands PD-L1 et PD-L2 (PD-Ls) perturbe la réponse immunitaire contre les pathogènes et les cellules tumorales.
     Les inhibiteurs de points de contrôle immunitaires (ICI) ciblant l'axe PD-1/PD-Ls représentent aujourd’hui une avancé majeure dans le traitement de différents types de cancer, tant sur le plan de l’efficacité que de la tolérance. Le nivolumab (nivo) et le pembrolizumab (pembro) sont deux anticorps monoclonaux (AcM) anti-PD-1 qui bloquent l’interaction de PD-1 avec ses ligands. Ces AcM ont montré des résultats prometteurs dans le traitement de multiples types de cancers comme le mélanome, le cancer bronchique non à petites cellules, le carcinome à cellules rénales, etc. 
     Malgré l’importance thérapeutique de nivo et de pembro dans le cancer, aucune étude n’a défini le devenir de PD-1 après la liaison à ces deux AcM. 
     L’objectif de cette étude a été donc d’évaluer l’endocytose de PD-1 suite au liaison à des AcM anti-PD-1 (clone J110, nivo, pembro) et de déterminer s’il y a différence entre nivo et pembro vis à vis leur capacités à induire l'internalisation de  PD-1.
      L’étude de l’endocytose de PD-1 a été réalisé sur des LT humains obtenus à partir du sang périphérique de donneurs sains et activés avec des Ac anti-CD3/anti-CD28 ou concanavaline A afin d’exprimer le récepteur PD-1. L’analyse des données par cytométrie en flux a montré que l’engagement de PD-1 avec l’Ac anti-PD-1 (clone J110) induit son endocytose dans les LT humains et que 50% de la totalité de PD-1 de surface est internalisé dans les premiers 30 minutes  suivant l’incubation de cellules à 37°C, suivi d’un taux d’endocytose plus lent (56% en 60min).
     Notre étude a montré également que la liaison de nivo et de pembro au PD-1 induit  son endocytose et que la plupart de récepteur est internalisée dans les 30 min suivant l’incubation de cellules à 37°C. Toutefois, 32 à 50% des récepteurs sont résistants à l’endocytose. 
      L’analyse comparative de nivo et de pembro a révélé une différence statistiquement significative (p=0.03) entre le taux d’internalisation du complexe PD-1/nivo et celui du PD-1/pembro (46% versus 25% en 30min, respectivement). Même à des concentrations élevées de pembro, la liaison de nivo induit une meilleure internalisation de PD-1, ce qui suggère que nivo pourrait être plus efficace.
      Bien que les ICI comme nivo et pembro sont connus de bloquer l’interaction de PD-1 avec ses ligands, PD-L1 et PD-L2, notre étude a montré pour la première fois que ce deux AcM induisent aussi l’endocytose du récepteur PD-1 dans les LT humains avec des taux différents, et que 32% à 50% de récepteurs PD-1 sont résistants à l’endocytose. Ces résultats pourraient être exploités pour améliorer l’internalisation de PD-1 dans les LT humains et par la suite augmenter les potentiels thérapeutiques de nivolumab et de pembrolizumab dans le traitement du cancer.

Mots clés : Récepteur PD-1, Ligands de PD-1, Lymphocytes T, Inhibiteurs de point de contrôle immunitaires, Anticorps anti-PD-1, Nivolumab, Pembrolizumab,  Endocytose, Cancer</td><td>fr</td>
</tr>
<tr class="ds-table-row even">
<td class="label-cell">dcterms.abstract</td><td class="word-break">PD-1 (Programmed Cell death protein -1) is a co-inhibitory receptor expressed on the surface of activated T cells. It plays an important role in maintaining peripheral tolerance and protecting against autoimmune and inflammatory diseases. However, permanent expression of PD-1 and its ligands PD-L1/ PD-L2 (PD-Ls) disrupts the immune response against pathogens and tumor cells.
      Immune checkpoint blockade (ICB) targeting the PD-1/PD-Ls axis has revolutionized the treatment of many cancers. Nivolumab (nivo) and pembrolizumab (pembro) are two anti-PD-1 monoclonal antibodies (mAb) that block the interaction between PD-1 and its ligands. They have shown promising results in the treatment of multiple types of cancers such as melanoma, non-small cell lung cancer, renal cell carcinoma, etc. 
     Surprisingly, despite the success of anti-PD-1 in cancer immunotherapy, no-one has defined the destiny of surface PD-1 following antibody binding. Therefore, the objective of my master thesis was to define the fate of surface PD-1 following antibody binding and whether different anti-PD-1 Abs in the clinic differ in their ability to induce PD-1 endocytosis.
       The study of PD-1 endocytosis was performed on human T lymphocytes obtained from peripheral blood of healthy donors and activated with anti-CD3/anti-CD28 Ab or concanavalin A to express PD-1 receptor. Data analysis by flow cytometry showed that following anti-PD-1 Ab binding, 50% of PD-1 becomes endocytosed by 30min.
      In addition, we found that the PD-1 receptor is internalised upon its engagement with nivo and pembro and that most of the receptor is endocytosed within 30 min. However, 32 to 50% of the receptors are resistant to endocytosis.
      The comparative analysis of nivo and pembro has revealed a statistically significant difference (p=0.03) between the internalisation rate of the PD-1/nivo complex versus PD-1/pembro (46% versus 25% by 30min, respectively). Even at high concentrations of pembro, nivo induces better internalization of PD-1, suggesting that nivo could be more effective than pembro.
   Our study showed for the first time that ICB involves not only in the blockade of PD-1/PD-Ls interaction, but also in the endocytosis of PD-1 receptors from the surface of human T-cells, which differs between nivolumab and pembrolizumab. These results could be exploited to increase the therapeutic potential of nivolumab and pembrolizumab in cancer treatment.

Keywords: PD-1 receptor, PD-1 ligands, T lymphocytes, Immune checkpoint blockade, Anti-PD1 antibodies, Nivolumab, Pembrolizumab, Endocytosis, Cancer</td><td>fr</td>
</tr>
<tr class="ds-table-row odd">
<td class="label-cell">dcterms.language</td><td class="word-break">fra</td><td>fr</td>
</tr>
</table>
</div>
<span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&amp;rft_id=http%3A%2F%2Fhdl.handle.net%2F1866%2F23924&amp;rfr_id=info%3Asid%2Fdspace.org%3Arepository&amp;rft.degree=Biologie+mol%C3%A9culaire&amp;rft.degree=Universit%C3%A9+de+Montr%C3%A9al&amp;rft.degree=Ma%C3%AEtrise+%2F+Master%27s&amp;rft.degree=M.+Sc."> ﻿ 
        </span>
<h3>Files in this item</h3>
<div class="file-list">
<div class="file-wrapper row">
<div class="col-xs-6 col-sm-3">
<div class="thumbnail-wrapper">
<a class="image-link" href="/xmlui/bitstream/handle/1866/23924/Ben_Saad_Elham_2019_memoire.pdf?sequence=4&amp;isAllowed=y"><img alt="Thumbnail" class="thumbnail-papyrus" src="/xmlui/bitstream/handle/1866/23924/Ben_Saad_Elham_2019_memoire.pdf.jpg?sequence=7&amp;isAllowed=y"/></a>
<div class="imageoverlay">
<img height="49" src="/xmlui/themes/Mirage2/images/mimes/mime_icone_pdf.png" style="height: 49px;" width="44"/></div>
</div>
</div>
<div class="col-xs-6 col-sm-7">
<dl class="file-metadata dl-horizontal">
<dt>Name:</dt>
<dd class="word-break" title="Ben_Saad_Elham_2019_memoire.pdf">
<a href="/xmlui/bitstream/handle/1866/23924/Ben_Saad_Elham_2019_memoire.pdf?sequence=4&amp;isAllowed=y">Ben_Saad_Elham_2019_memoire.pdf</a>
</dd>
<dt>Size:</dt>
<dd class="word-break">17.03Mb</dd>
<dt>Format:</dt>
<dd class="word-break">PDF</dd>
<dt>Description:</dt>
<dd class="word-break" title="Mémoire">Mémoire</dd>
</dl>
</div>
</div>
</div>
<h3 class="ds-list-head">This item appears in the following Collection(s)</h3>
<ul class="ds-referenceSet-list">
<!-- External Metadata URL: cocoon://metadata/handle/1866/2621/mets.xml-->
<li>
<a href="/xmlui/handle/1866/2621">Thèses et mémoires électroniques de l’Université de Montréal</a> [18270]<br/>
</li>
<!-- External Metadata URL: cocoon://metadata/handle/1866/2591/mets.xml-->
<li>
<a href="/xmlui/handle/1866/2591">Faculté de médecine – Thèses et mémoires</a> [4267]<br/>
</li>
</ul>
<p class="ds-paragraph item-view-toggle item-view-toggle-bottom">
<span class="item-view-toggle"><a href="/xmlui/handle/1866/23924">Show item record</a></span>
</p>
</div>
</div>
<div class="visible-xs visible-sm">
<footer>
<div class="row">
<hr/>
<div class="col-xs-7 col-sm-8">
<div>
<a href="http://www.dspace.org/" target="_blank">DSpace software</a>
                        [version 5.8 XMLUI],
                        copyright © 2002-2015  <a href="http://www.duraspace.org/" target="_blank">DuraSpace</a>
</div>
<div class="hidden-print">
<a href="/xmlui/contact">Contact Us</a> | <a href="/xmlui/feedback">Send Feedback</a>
</div>
</div>
<div class="col-xs-5 col-sm-4 hidden-print">
<div class="pull-right">
<script type="text/javascript"> 
										      (function(d, t) { 
										        var s = d.createElement(t), options = {'domain':'papyrus.bib.umontreal.ca','style': '16','container':'entrust-net-seal'}; 
										        s.src = 'https://seal.entrust.net/sealv2.js'; 
										        s.async = true; 
										        var scr = d.getElementsByTagName(t)[0], par = scr.parentNode; par.insertBefore(s, scr); 
										        s.onload = s.onreadystatechange = function() { 
										        var rs = this.readyState; if (rs) if (rs != 'complete') if (rs != 'loaded') return; 
										        try{goEntrust(options)} catch (e) {} }; 
										        })(document, 'script'); 
										</script>
<div id="entrust-net-seal">
<a href="https://www.entrust.com/ssl-certificates/">Certificat SSL / SSL Certificate</a>
</div>
</div>
</div>
</div>
<div class="row bib-footer hidden-print">
<div class="col-xs-12 col-sm-12 col-md-4">
<a class="footerEXLlink" href="http://www.bib.umontreal.ca"><img alt="les bibliothèques/UdeM" src="/xmlui/themes/Mirage2/images/propulse-par.png"/></a>
</div>
<div class="hidden-xs col-sm-12 col-md-8">
<nav>
<ul>
<li>
<a href="https://www.urgence.umontreal.ca/">Emergency</a>
</li>
<li>
<a href="http://www.carrieres.umontreal.ca/">Careers</a>
</li>
<li>
<a href="https://outlook.umontreal.ca/">My email</a>
</li>
<li>
<a href="https://studium.umontreal.ca/">StudiUM</a>
</li>
<li>
<a href="http://itunesu.umontreal.ca/">iTunes U</a>
</li>
<li>
<a href="http://www.bib.umontreal.ca/a-propos/nous-ecrire.htm">Contact us</a>
</li>
<li>
<a href="https://www.facebook.com/bibUdeM"><img alt="Facebook" src="/xmlui/themes/Mirage2/images/bib-umontreal/logo-Facebook.png"/></a>
</li>
<li>
<a href="https://www.youtube.com/user/BibliothequesUdeM"><img alt="YouTube" src="/xmlui/themes/Mirage2/images/bib-umontreal/logo-YouTube.png"/></a>
</li>
<li>
<a href="https://twitter.com/bibUdeM"><img alt="Twitter" src="/xmlui/themes/Mirage2/images/bib-umontreal/logo-Twitter.png"/></a>
</li>
<li>
<a href="https://www.nouvelles.umontreal.ca/frontpage/rss.html"><img alt="University RSS" src="/xmlui/themes/Mirage2/images/bib-umontreal/icone-syndication-14x14.png"/></a>
</li>
</ul>
</nav>
</div>
</div>
<a class="hidden" href="/xmlui/htmlmap"> </a>
<p> </p>
</footer>
</div>
</div>
</div>
</div>
<div class="hidden-xs hidden-sm">
<footer>
<div class="row">
<hr/>
<div class="col-xs-7 col-sm-8">
<div>
<a href="http://www.dspace.org/" target="_blank">DSpace software</a>
                        [version 5.8 XMLUI],
                        copyright © 2002-2015  <a href="http://www.duraspace.org/" target="_blank">DuraSpace</a>
</div>
<div class="hidden-print">
<a href="/xmlui/contact">Contact Us</a> | <a href="/xmlui/feedback">Send Feedback</a>
</div>
</div>
<div class="col-xs-5 col-sm-4 hidden-print">
<div class="pull-right">
<script type="text/javascript"> 
										      (function(d, t) { 
										        var s = d.createElement(t), options = {'domain':'papyrus.bib.umontreal.ca','style': '16','container':'entrust-net-seal'}; 
										        s.src = 'https://seal.entrust.net/sealv2.js'; 
										        s.async = true; 
										        var scr = d.getElementsByTagName(t)[0], par = scr.parentNode; par.insertBefore(s, scr); 
										        s.onload = s.onreadystatechange = function() { 
										        var rs = this.readyState; if (rs) if (rs != 'complete') if (rs != 'loaded') return; 
										        try{goEntrust(options)} catch (e) {} }; 
										        })(document, 'script'); 
										</script>
<div id="entrust-net-seal">
<a href="https://www.entrust.com/ssl-certificates/">Certificat SSL / SSL Certificate</a>
</div>
</div>
</div>
</div>
<div class="row bib-footer hidden-print">
<div class="col-xs-12 col-sm-12 col-md-4">
<a class="footerEXLlink" href="http://www.bib.umontreal.ca"><img alt="les bibliothèques/UdeM" src="/xmlui/themes/Mirage2/images/propulse-par.png"/></a>
</div>
<div class="hidden-xs col-sm-12 col-md-8">
<nav>
<ul>
<li>
<a href="https://www.urgence.umontreal.ca/">Emergency</a>
</li>
<li>
<a href="http://www.carrieres.umontreal.ca/">Careers</a>
</li>
<li>
<a href="https://outlook.umontreal.ca/">My email</a>
</li>
<li>
<a href="https://studium.umontreal.ca/">StudiUM</a>
</li>
<li>
<a href="http://itunesu.umontreal.ca/">iTunes U</a>
</li>
<li>
<a href="http://www.bib.umontreal.ca/a-propos/nous-ecrire.htm">Contact us</a>
</li>
<li>
<a href="https://www.facebook.com/bibUdeM"><img alt="Facebook" src="/xmlui/themes/Mirage2/images/bib-umontreal/logo-Facebook.png"/></a>
</li>
<li>
<a href="https://www.youtube.com/user/BibliothequesUdeM"><img alt="YouTube" src="/xmlui/themes/Mirage2/images/bib-umontreal/logo-YouTube.png"/></a>
</li>
<li>
<a href="https://twitter.com/bibUdeM"><img alt="Twitter" src="/xmlui/themes/Mirage2/images/bib-umontreal/logo-Twitter.png"/></a>
</li>
<li>
<a href="https://www.nouvelles.umontreal.ca/frontpage/rss.html"><img alt="University RSS" src="/xmlui/themes/Mirage2/images/bib-umontreal/icone-syndication-14x14.png"/></a>
</li>
</ul>
</nav>
</div>
</div>
<a class="hidden" href="/xmlui/htmlmap"> </a>
<p> </p>
</footer>
</div>
</div>
<script src="https://www.google.com/jsapi"> </script><script>if(!window.DSpace){window.DSpace={};}window.DSpace.context_path='/xmlui';window.DSpace.theme_path='/xmlui/themes/Mirage2/';</script><script src="/xmlui/themes/Mirage2/scripts/theme.js"> </script><script>
                  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
                  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
                  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
                  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

                  ga('create', 'UA-305727-1', 'papyrus.bib.umontreal.ca');
                  ga('send', 'pageview');
           </script><script>         
             var details_Papyrus =  $("#aspect_viewArtifacts_Navigation_list_account .details_Papyrus").text();
             $("#aspect_viewArtifacts_Navigation_list_account a[href='/xmlui/login']").attr("title",details_Papyrus);
        </script>
</body></html>
